PCI术后双联抗血小板治疗时限再探讨——EXCELLENT试验解读
摘要
药物洗脱支架(drug eluting stent,DES)能有效降低经皮冠状动脉介入(percutaneous coronary intervention,PCI)术后再狭窄发生率,但近年DES支架内晚期和超晚期血栓形成所导致的死亡和心肌梗死风险引起越来越多的关注。提前中断的双联抗血小板(dual antiplatelet,DAPT)治疗被认为是最强的影响支架内血栓形成的危险因素,
出处
《中日友好医院学报》
2013年第1期54-56,共3页
Journal of China-Japan Friendship Hospital
参考文献9
-
1Bonaca MP,Wiviott SD,Braunwald E. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death:observations from the TRITON-TIMI 38 trial(Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infar[J].Circulation,2012,(04):577-583.
-
2ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force on the management of ST-segment elevation acute myocardial infarction of the european society of cardiology(ESC). ESC Committee for Practice Guidelines[J].European Heart Journal,2012.24.
-
3Gwon HC,Hahn JY,Park KW. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents:the efficacy of xience/promus versus cypher to reduce late loss after stenting(EXCELLENT)randomized,multicenter study[J].Circulation,2012,(03):505-513.
-
4Park SJ,Park DW,Kim YH. Duration of dual antiplatelet therapy after implantation of drug-eluting stents[J].New England Journal of Medicine,2010,(15):1374-1382.
-
5Airoldi F,Colombo A,Morici N. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment[J].Circulation,2007,(07):745-754.
-
6Kimura T,Morimoto T,Nakagawa Y. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation[J].Circulation,2009,(07):987-995.doi:10.1161/CIRCULATIONAHA.108.808311.
-
7Hahn JY,Song YB,Choi JH. Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents:the DATE(Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent)registry[J].Circulation,2010,(11):2314-2321.
-
8Silber S,Windecker S,Vranckx P. RESOLUTE all comers investigators.Unrestricted randomised use of two new generation drug-eluting coronary stents:2-year patient-related versus stent-related outcomes from the RESOLUTE all comers trial[J].The Lancet,2011,(9773):1241-1247.
-
9中国经皮冠状动脉介入治疗指南2012(简本)[J].中华心血管病杂志,2012,40(4):271-277. 被引量:424
二级参考文献10
-
1Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555.
-
2Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651.
-
3Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210.
-
4Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13.
-
5Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972.
-
6Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932.
-
7Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx.
-
8Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243.
-
9Mehta SR, Granger CB, Eikelboom JW, et al. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Cell Cardiol,2007,50 : 1742-1751.
-
10Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation, 2011,123:2736-2747.
共引文献423
-
1顾若曦,于晓雪,王萍,周铁楠,赵昕,王效增.女性冠心病患者择期行经皮冠状动脉介入治疗使用比伐芦定疗效及安全性分析[J].临床军医杂志,2020(10):1196-1199. 被引量:2
-
2中华中医药学会介入心脏病学专家委员会,海峡两岸医药卫生交流协会中西医结合专业委员会,中国老年学学会心脑血管专业委员会,北京中医药大学心血管病研究所,王显.经皮冠状动脉介入治疗手术前后抑郁和(或)焦虑中医诊疗专家共识[J].中国循环杂志,2014,29(S02):151-157. 被引量:3
-
3中华中医药学会介入心脏病学专家委员会,海峡两岸医药卫生交流协会中西医结合专业委员会,中国老年学学会心脑血管病专业委员会,北京中医药大学心血管病研究所,王显.经皮冠状动脉介入治疗术后胸痛中医诊疗专家共识[J].中国循环杂志,2014,29(S02):141-146. 被引量:1
-
4高润霖.遵循指南 进一步规范冠心病介入治疗——中国经皮冠状动脉介入治疗指南2012解读[J].中国循环杂志,2012,27(S01):3-5. 被引量:17
-
5戈美琴,李秀霞,张俞,邓志云.电话回访制对冠脉支架术后患者自我护理能力的影响[J].医学信息(医学与计算机应用),2014,0(25):116-117. 被引量:3
-
6杜雪莲,高志胜,唐诗玲,王莉,宋坤青.延续护理对替格瑞洛治疗急性冠脉综合症患者依从性的影响[J].糖尿病天地,2018,15(7):207-208.
-
7钱晓明.医院老年病管理与多维度综合评估[J].医学研究生学报,2012,25(9):897-900. 被引量:11
-
8李群,李莉娜,程宇彤,刘彤.高龄冠心病患者行冠状动脉介入治疗的风险及疗效评价[J].心肺血管病杂志,2012,31(6):666-668. 被引量:9
-
9彭程,何继强,玉献鹏,罗亚玮,高阅春,吴长燕,张晓玲,张宇晨,陈方.SYNTAX积分和GRC对复杂冠心病患者经皮冠状动脉介入治疗预后的预测作用研究[J].中国全科医学,2013,16(1):36-39. 被引量:7
-
10陈志楠.急性心肌梗死临床相关问题[J].医学新知,2013(1):9-12.
-
1袁晋青,许晶晶.经皮冠状动脉介入治疗术后双联抗血小板治疗时限的最新证据[J].中国循环杂志,2015,30(2):101-104. 被引量:10
-
2董晶,刘东方,郑涛.暴发性心肌炎诊治过程中的心电图表现[J].辽宁医学杂志,2009,23(4):177-178. 被引量:6
-
3张新勇,马长生.药物洗脱支架与支架内再狭窄[J].临床心血管病杂志,2009,25(7):486-487. 被引量:17
-
4杨明,娄光学,郭建辉.泛影葡胺在粘连性肠梗阻治疗中的应用[J].现代医药卫生,2009,25(8):1183-1185. 被引量:1
-
5王成全,李剑,冯雪影,吴海霞.经皮冠状动脉介入治疗术后晚期血栓形成1例[J].临床荟萃,2010,25(21):1923-1923.
-
6李静静,廉哲勋.药物洗脱支架植入后31个月迟发晚期血栓形成1例[J].齐鲁医学杂志,2008,23(4):366-366.
-
7王可,于曼丽,赵仙先.心肌梗死患者心功能的预测因素[J].中国心血管病研究,2009,7(6):475-478. 被引量:2
-
8巴·巴音斯勒玛,马依彤,于子翔,杨毅宁,马翔,李晓梅,谢翔.经皮冠脉介入术后双联抗血小板治疗时限的系统评价[J].中国循证医学杂志,2012,12(5):577-582. 被引量:8
-
9陈晞明,陈次滨,卢雄.西罗莫司药物洗脱支架植入后极晚期血栓形成1例[J].岭南心血管病杂志,2009,15(1):65-66.
-
10高筱红,姚远,魏广林,张崟,马长生.雷帕霉素洗脱支架晚期血栓形成一例[J].中国心血管病研究,2008,6(1):80-80.